Fol. Biol. 2001, 47, 206-210
https://doi.org/10.14712/fb2001047060206
Detection of Minimal Bone Marrow Infiltration in Patients with Localized and Metastatic Ewing Sarcoma Using RT-PCR
References
1. 2001) Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumours and desmoplastic small round cell tumour. J. Ped. Hematol. Oncol. 23, 99-104.
< , U. H., Shurtleff, S. A., Jenkins, J. J., Poquette, C. A., Tan, M., Downing, J. R., Pappo, A. S. (https://doi.org/10.1097/00043426-200102000-00006>
2. 1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
< , P., Sacchi, N. (https://doi.org/10.1016/0003-2697(87)90021-2>
3. 2000) Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumour family. J. Clin. Oncol. 18, 204-213.
< , E., Gerald, W. L. (https://doi.org/10.1200/JCO.2000.18.1.204>
4. 1998) EWS-FLI-1 fusions transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J. Clin. Oncol. 16, 1248-1255.
< , E., Kawai, E., Healey, J. H., Fligman, I., Meyers, P. A., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., Pardo-Mindan, F. J., Ginsberg, J., Womer, R., Lawlor, E. R., Wunder, J., Andrulis, I., Sorensen, P. H. B., Barr, F. G., Ladanyi, M. (https://doi.org/10.1200/JCO.1998.16.4.1248>
5. 1994) The Ewing family of tumours a subgroup of small-round-cell tumours defined by specific chimeric transcripts. N. Engl. J. Med. 331, 294-299.
< , O., Zucman, J., Melot, T., Garau, X. S., Zucker, J. M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., Aurias, A., Thomas, G. (https://doi.org/10.1056/NEJM199408043310503>
6. 1997) Multiple chromosomal mechanisms generate an EWS/FLI-1 or an EWS/ERG fusion gene in Ewing tumours. Cancer Genet. Cytogenet. 97, 12-19.
< , C., Brizard, F., Turc-Carel, C., Melot, T., Delattre, O., Thomas, G., Aurias, A. (https://doi.org/10.1016/S0165-4608(96)00326-3>
7. 1998) Presence of tumour cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumour. J. Clin. Oncol. 16, 1707-1711.
< , C., Michon, J., Peter, M., Bernoux, A., Oberlin, O., Zucker, J. M., Magdelenat, H., Delattre, O. (https://doi.org/10.1200/JCO.1998.16.5.1707>
8. 1999) EWS-FLI-1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. J. Clin. Oncol. 17, 1809-1814.
< , J. P., de Alava, E., Ladanyi, M., Wexler, L. H., Kovar, H., Kovar, H., Paulussen, M., Zoubek, A., Dockhorn-Dworniczak, B., Jürgens, H., Wunder, J. S., Andrulis, I. L., Malik, R., Sorensen, P. H. B., Womer, R. B., Barr, F. G. (https://doi.org/10.1200/JCO.1999.17.6.1809>
9. Horowitz, M. E., Malawer, M. M., Woo, S. Y., Hicks, M. J. (1997) Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumours. In: Principles and Practice of Pediatric Oncology, eds. Pizzo, P. A., Poplack, D. G., pp. 831-864, Lippincott, Philadelphia.
10. Jürgens, H., Barrett, A., Dockhorn-Dworniczak, B., Winkelmann, W. (1998) Ewing's sarcoma. In: Cancer in Children, eds. Voute, P. A., Kalifa, C., Barrett, pp. 232-258, Oxford University Press, Oxford.
11. 1998) Absence of detectable EWS/FLI-1 expression after therapy induced neural differentiation in Ewing sarcoma. Hum. Pathol. 29, 289-294.
< , S. R., Hendson, G., Mathers, J. A., Carpenter, B., Lopez-Terrada, D., Brown, K. L., Sorensen, P. Н. В. (https://doi.org/10.1016/S0046-8177(98)90049-1>
12. 1998) Ewing's sarcoma and peripheral primitive neuroectodermal tumours after their genetic union. Curr. Opin. Oncol. 10, 334-342.
< , H. (https://doi.org/10.1097/00001622-199807000-00010>
13. 2001) How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumour metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and literature review. J. Clin. Oncol. 19, 870-880.
< , B. H., Meyers, P. A. (https://doi.org/10.1200/JCO.2001.19.3.870>
14. 1999) Differential transactivation by alternative EWS-FLI-1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res. 59, 1428-1432.
, P. P., Brody, R. I., Hamelin, A. C., Bradner, J. E., Healey, J. H., Ladanyi, M. (
15. 2000) Soft tissue Ewing sarcoma-peripheral primitive neuroectodermal tumour with atypical clear cell pattern shows a new type of EWS-FEV fusion transcript. Diagn. Mol. Pathol. 9, 137-144.
< , A., Pellin, A., Carda, C., Noguera, R. Navarro, S., Peydró-Olaya, A. (https://doi.org/10.1097/00019606-200009000-00003>
16. 2000) The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 14, 7393-7398.
, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lusford, L. B., Hromas, R., Denny, C. T. (
17. 1998) Molecular diagnosis of Ewing tumours: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid combination of exon combinations. Diagn. Mol. Pathol. 7, 29-35.
< , V. S., Kühne, T., Jundt, G., Gudat, F. (https://doi.org/10.1097/00019606-199802000-00006>
18. 1995) Incidence of bone marrow involvement in Ewing's sarcoma: value of extensive investigation of bone marrow. Med. Ped. Oncol. 24, 343-346.
< , O., Bayle, C., Hartmann, O., Terrier-Lacombe, M. J., Lemerle, J. (https://doi.org/10.1002/mpo.2950240602>
19. 1993) EWS/FLI-1 chimeric protein is a transcriptional activator. Cancer Res. 53, 5859-5863.
, T., Rao, V. N., Reddy, S. P. (
20. 1995) Sensitive detection of occult Ewing's cells by the reverse-transcriptase polymerase chain reaction. Br. J. Cancer 72, 96-100.
< , M., Magdelenat, H., Michon, J., Melot, T., Oberlin, O., Zucker, J. M., Thomas, G., Delattre, O. (https://doi.org/10.1038/bjc.1995.283>
21. 1995) Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR. Int. J. Cancer 64, 135-139.
< , C., Zoubek, A., Gruber, B., Kronberger, M., Ambros, P. F., Lion, T., Fink, F. M., Gadner, H., Kovar, H. (https://doi.org/10.1002/ijc.2910640211>
22. 2001) Updates on cytogenetics and molecular genetics of bone and soft tissue tumours: Ewing sarcoma and peripheral primitive neuroectodermal tumours. Cancer Genet. Cytogenet. 123, 1-26.
< , A. A., Bridge, J. A. (https://doi.org/10.1016/S0165-4608(00)00295-8>
23. 2000) Ewing sarcoma family of tumours. Curr. Opin. Oncol. 12, 323-329.
< , D. C. (https://doi.org/10.1097/00001622-200007000-00008>
24. 1997) Detection of circulating tumour cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumour. J. Clin. Oncol. 15, 583-588.
< , D. C., Grier, H. E., Swallow, M. M., Demetri, G. D., Granowetter, L., Sklar, J. (https://doi.org/10.1200/JCO.1997.15.2.583>
25. 1994) Varibility of EWS chimeric transcripts in Ewing tumours: a comparison of clinical and molecular data. Br. J. Cancer 70, 908-913.
< , A., Pfleiderer, C., Salzer-Kuntschik, M., Amann, G., Windhager, R., Fink, F. M., Koscielniak, E., Delattre, O., Strehl, S., Ambros, P. F., Gadner, H., Kovar, H. (https://doi.org/10.1038/bjc.1994.419>
26. 1998) Predictive potential of testing for bone marrow involvement in Ewing tumour patients by RT-PCR: a preliminary evaluation. Int. J. Cancer 79, 56-60.
< , A., Ladenstein, R., Windhager, R., Amann, G., Fischmeister, G., Kager, L., Jugovic, D., Ambros, P. F., Gadner, H., Kovar, H. (https://doi.org/10.1002/(SICI)1097-0215(19980220)79:1<56::AID-IJC11>3.0.CO;2-F>